WO2012096436A3 - Animal à modèle de lésion pulmonaire provoquée par une exposition à l'hyperoxie, et trousse pour diagnostiquer une lésion pulmonaire provoquée par une exposition à l'hyperoxie par utilisation d'un marqueur taz - Google Patents
Animal à modèle de lésion pulmonaire provoquée par une exposition à l'hyperoxie, et trousse pour diagnostiquer une lésion pulmonaire provoquée par une exposition à l'hyperoxie par utilisation d'un marqueur taz Download PDFInfo
- Publication number
- WO2012096436A3 WO2012096436A3 PCT/KR2011/008808 KR2011008808W WO2012096436A3 WO 2012096436 A3 WO2012096436 A3 WO 2012096436A3 KR 2011008808 W KR2011008808 W KR 2011008808W WO 2012096436 A3 WO2012096436 A3 WO 2012096436A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- taz
- caused
- mice
- hyperoxia
- lung injury
- Prior art date
Links
- 206010058490 Hyperoxia Diseases 0.000 title abstract 8
- 230000000222 hyperoxic effect Effects 0.000 title abstract 8
- 208000004852 Lung Injury Diseases 0.000 title abstract 4
- 206010069363 Traumatic lung injury Diseases 0.000 title abstract 4
- 231100000515 lung injury Toxicity 0.000 title abstract 4
- 241001465754 Metazoa Species 0.000 title abstract 2
- 239000003550 marker Substances 0.000 title abstract 2
- 210000004072 lung Anatomy 0.000 abstract 7
- 241000699670 Mus sp. Species 0.000 abstract 5
- 201000010260 leiomyoma Diseases 0.000 abstract 5
- 230000002950 deficient Effects 0.000 abstract 3
- 238000010172 mouse model Methods 0.000 abstract 2
- 101150025256 TAZ gene Proteins 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 230000013632 homeostatic process Effects 0.000 abstract 1
- 230000036542 oxidative stress Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0276—Knock-out vertebrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/35—Animals modified by environmental factors, e.g. temperature, O2
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Animal Husbandry (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- Plant Pathology (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
La présente invention porte sur un animal à modèle de lésion pulmonaire provoquée par une exposition à l'hyperoxie, et sur une trousse pour diagnostiquer une lésion pulmonaire provoquée par une exposition à l'hyperoxie par utilisation d'un marqueur TAZ. Un poumon fibroïde séreux a été induit dans des souris à déficience en TAZ (TAZ-/-), et ceci était similaire à un poumon fibroïde se produisant dans les poumons de souris dans un groupe normal qui ont été exposées à l'hyperoxie. TAZ supprime des molécules-signaux par affectation d'un chemin de signal relatif au stress oxydant, permettant à l'hémostase de poumons d'être contrôlée. Par conséquent, les souris à déficience en TAZ (TAZ-/-) peuvent être utilisées de manière utile en tant que souris à modèle de poumon fibroïde provoqué par une exposition à l'hyperoxie, et également utilisées pour la préparation de souris à modèle de poumon fibroïde provoqué par une exposition à l'hyperoxie, et lors du dépistage de substances candidates pour traiter des agents à l'aide des souris. En outre, les souris à déficience en TAZ (TAZ-/-) peuvent être utilisées pour diagnostiquer un poumon fibroïde provoqué par une exposition à l'hyperoxie et une trousse de diagnostic peut être utilisée à cet effet, par confirmation de l'expression du gène ou de la protéine TAZ.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2011-0003666 | 2011-01-13 | ||
KR1020110003666A KR101300777B1 (ko) | 2011-01-13 | 2011-01-13 | 과산소 노출에 의한 폐손상 모델 동물, 및 taz 마커를 이용한 과산소 노출에 의한 폐손상 진단용 키트 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012096436A2 WO2012096436A2 (fr) | 2012-07-19 |
WO2012096436A3 true WO2012096436A3 (fr) | 2012-09-07 |
Family
ID=46507526
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2011/008808 WO2012096436A2 (fr) | 2011-01-13 | 2011-11-17 | Animal à modèle de lésion pulmonaire provoquée par une exposition à l'hyperoxie, et trousse pour diagnostiquer une lésion pulmonaire provoquée par une exposition à l'hyperoxie par utilisation d'un marqueur taz |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR101300777B1 (fr) |
WO (1) | WO2012096436A2 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102162289B1 (ko) * | 2017-11-28 | 2020-10-06 | 충남대학교 산학협력단 | Golga2 유전자 넉아웃 폐 섬유화 마우스 모델 |
KR102162283B1 (ko) * | 2017-11-28 | 2020-10-06 | 충남대학교 산학협력단 | Golga2 유전자 넉아웃 간 섬유화 마우스 모델 |
KR102235072B1 (ko) * | 2018-04-19 | 2021-04-02 | 이화여자대학교 산학협력단 | Taz 폴리펩티드를 포함하는 폐 질환 예방 또는 치료용 약학적 조성물 및 이를 이용한 방법 |
US20230028447A1 (en) * | 2018-05-04 | 2023-01-26 | Samsung Life Public Welfare Foundation | Screening method for therapeutic substance for preventing or treating bronchopulmonary dysplasia (bpd) |
CN115772539A (zh) * | 2022-11-17 | 2023-03-10 | 南京医科大学 | 一种具有ⅰ型气管发育不全表型的双侧肺脏缺失小鼠模型及其构建方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060056948A1 (en) * | 2004-08-04 | 2006-03-16 | Agency For Science, Technology And Research | Methods |
US20100263064A1 (en) * | 2003-05-30 | 2010-10-14 | Boucher Jr Richard C | Animal model for chronic obstructive pulmonary disease and cystic fibrosis |
-
2011
- 2011-01-13 KR KR1020110003666A patent/KR101300777B1/ko active IP Right Grant
- 2011-11-17 WO PCT/KR2011/008808 patent/WO2012096436A2/fr active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100263064A1 (en) * | 2003-05-30 | 2010-10-14 | Boucher Jr Richard C | Animal model for chronic obstructive pulmonary disease and cystic fibrosis |
US20060056948A1 (en) * | 2004-08-04 | 2006-03-16 | Agency For Science, Technology And Research | Methods |
Non-Patent Citations (2)
Title |
---|
MAKITA, R. ET AL.: "Multiple renal cysts, urinary concentration defects, and pulmonary emphysematous changes in mice lacking TAZ'", AM. J. PHYSIOL. RENAL PHYSIOL., vol. 294, 2008, pages F542 - F553 * |
MITANI, A. ET AL.: "Transcriptional coactivator with PDZ-binding motif is essential for normal alveolarization in mice", AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, vol. 180, 2009, pages 326 - 338 * |
Also Published As
Publication number | Publication date |
---|---|
KR20120082271A (ko) | 2012-07-23 |
WO2012096436A2 (fr) | 2012-07-19 |
KR101300777B1 (ko) | 2013-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2013066764A3 (fr) | Marqueurs de signature de la maladie d'alzheimer et procédés d'utilisation | |
WO2012096436A3 (fr) | Animal à modèle de lésion pulmonaire provoquée par une exposition à l'hyperoxie, et trousse pour diagnostiquer une lésion pulmonaire provoquée par une exposition à l'hyperoxie par utilisation d'un marqueur taz | |
WO2008089994A8 (fr) | Utilisation de igfbp-7 dans l'évaluation d'une insuffisance cardiaque | |
WO2009090553A3 (fr) | Compositions et procédés de détection de peptides post-arrêts | |
ATE554389T1 (de) | Apex als marker für lungenkrebs | |
WO2014045254A3 (fr) | Lignée c de coronavirus bêta humains et identification de la peptidase dipeptidylique n-terminale en tant que récepteur viral | |
WO2011156734A3 (fr) | Procédé de caractérisation de maladies vasculaires | |
CR20110470A (es) | Proteínas de union a il-17 | |
WO2011027990A3 (fr) | Vésicules extracellulaires issues de bactéries à gram positif et leur utilisation | |
WO2013033609A3 (fr) | Méthodes et compositions pour le traitement et le diagnostic du cancer | |
PH12015502849B1 (en) | Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers | |
WO2011002834A3 (fr) | Compositions et procédés de diagnostic et de traitement du diabète de type i | |
DE602006021038D1 (de) | Verfahren zur diagnose eines ovarialkarzinoms | |
WO2012102535A3 (fr) | Composition permettant de détecter des protéines contenant un biomatériau couplé à un oxyde de tyrosine | |
ES2578477T3 (es) | ASC como marcador de la enfermedad pulmonar obstructiva crónica (EPOC) | |
BR112013021056A2 (pt) | anticorpo monoclonal, linhagem de células de hibridoma, kit para diagnóstico, métodos para a produção de um anticorpo monoclonal e de um agente de ligação, agente de ligação sequência de aminoácidos purificada, método para a obtenção de uma sequência do ácido nucleico codificante, molécula do ácido nucleico isolado codificante, vetor, célula hospedeira isolada, proteína de fusão, método de triagem para a presença de uma doença, de uma condição, métodos de diagnóstico de um indivíduo, de prognóstico para um indivíduo, e de monitoramento de um indivúdo, e, método para detecção da presença ou ausência de um câncer cervical | |
BR112014031957A2 (pt) | bag3 como soro bioquímico e marcador de tecido | |
WO2013009146A3 (fr) | Marqueur pour le diagnostic d'une rétinopathie diabétique | |
HK1136873A1 (en) | Use of nnmt as a marker for lung cancer | |
WO2010000467A8 (fr) | Asc en tant que marqueur du cancer du poumon | |
ATE554388T1 (de) | Verfahren und immunabsorbentien zur spezifischen detektion und absorption zöliakie- und dermatitis herpetiformis assoziierter antikörper | |
WO2013009143A3 (fr) | Marqueur pour le diagnostic d'une rétinopathie diabétique | |
ES2509567T3 (es) | Identificación de variación genética en tejidos afectados | |
MY148542A (en) | A method for the assessment of cancer in a biological sample obtained from a subject | |
WO2010000874A3 (fr) | Séquences de marqueurs pour maladies inflammatoires de la prostate, le cancer de la prostate, et leurs utilisations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11855503 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11855503 Country of ref document: EP Kind code of ref document: A2 |